NOT-CA-23-022: Notice of Pre-Application Webinar for the Pre-Competitive Collaboration on Liquid Biopsy for Early Cancer Assessment Program: RFA-CA-23-018 and RFA-CA-23-019

Notice of Pre-Application Webinar for the “Pre-Competitive Collaboration on Liquid Biopsy for Early Cancer Assessment” Program: RFA-CA-23-018 and RFA-CA-23-019

Notice Number:

NOT-CA-23-022

Key Dates

Release Date:

December 7, 2022

Related Announcements

RFA-CA-23-018 - Pre-Competitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed)

RFA-CA-23-019 - Pre-Competitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a public pre-application teleconference on December 22, 2022, at 1:00-2:00 pm (ET) for the Pre-Competitive Collaboration on Liquid Biopsy for Early Cancer Assessment (LBC) Funding Opportunity Announcements (FOAs):

1) RFA-CA-23-018 - Pre-Competitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed); and

2) RFA-CA-23-019 - Pre-Competitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)

NCI staff members involved in managing the LBC program will provide technical assistance to potential applicants by explaining the goals and objectives of this initiative and answering questions from attendees.

Potential applicants are encouraged to submit their questions or comments to Dr. Lynn Sorbara ([email protected]) or Dr. Christos Patriotis ([email protected]) in advance of the teleconference. Please include "NCI Technical Assistance Webinar for LBC FOAs” in the subject line of the email.

Registration: Potential applicants interested in participating in the teleconference should send an e-mail to Mr. Juan Miguel Villanueva ([email protected]) no later than 5:00 p.m. (ET), December 20, 2022. Please include “Registration for Pre-Application Webinar for LBC FOAs” in the subject line of the email. Upon receipt, a confirmation e-mail will be sent together with a calendar invitation that will also include a Webex link for joining the teleconference on December 22, 2022.

Participation in this teleconference, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-23-018 or RFA-CA-23-019.

Inquiries

Please direct all inquiries to:

Lynn Sorbara, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7135
Email: [email protected]

Christos Patriotis, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7134
Email: [email protected]